Alan E Mast

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 15

Top Topics

Mild Traumatic Brain Injury

Gene Expression

Venous Thromboembolism

Top Venues

Journal of thrombosis and haemostasis : JTH

American journal of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Yaqiu Sang, Robert Hugh Lee, Annie Luong, Éva Katona, Claire S Whyte, Nicholas L Smith, Alan E Mast, Matthew J Flick, Nicola J Mutch, Wolfgang Bergmeier, Alisa S Wolberg
Activated platelets retain and protect most of their factor XIII-A cargo from proteolytic activation and degradation. Blood advances (2024)
Alan E Mast, Alisa S Wolberg, David Gailani, Michael R Garvin, Christiane Alvarez, J Izaak Miller, Piet Jones, Bruce Aronow, Daniel A Jacobson
Response to comment on 'SARS-CoV-2 suppresses anticoagulant and fibrinolytic gene expression in the lung'. eLife 11 (2022)
Alan E Mast, Wolfram Ruf
Regulation of coagulation by tissue factor pathway inhibitor: Implications for hemophilia therapy. Journal of thrombosis and haemostasis : JTH 20 (6) (2022)
Julie A Peterson, Sweta Gupta, Nicholas D Martinez, Brandon Hardesty, Susan A Maroney, Alan E Mast
Factor V east Texas variant causes bleeding in a three-generation family. Journal of thrombosis and haemostasis : JTH (2021)
Piyushkumar R Kapopara, Nooshin S Safikhan, Jenny L Huang, Scott C Meixner, Kevin Gonzalez, Houra Loghmani, Wolfram Ruf, Alan E Mast, Victor Lei, Edward L G Pryzdial, Edward M Conway
CD248 enhances tissue factor procoagulant function, promoting arterial and venous thrombosis in mouse models. Journal of thrombosis and haemostasis : JTH 19 (8) (2021)
Alan E Mast, Alisa S Wolberg, David Gailani, Michael R Garvin, Christiane Alvarez, J Izaak Miller, Bruce Aronow, Daniel A Jacobson
SARS-CoV-2 suppresses anticoagulant and fibrinolytic gene expression in the lung. eLife 10 (2021)
Hefei Liu, Robert T Burns, Bryan R Spencer, Grier P Page, Alan E Mast, null null
Demographic, clinical, and biochemical predictors of pica in a large cohort of blood donors. Transfusion 61 (7) (2021)
Amy E Siebert, Susan A Maroney, Nicholas D Martinez, Alan E Mast
Intrauterine lethality in Tfpi gene disrupted mice is differentially suppressed during mid- and late-gestation by platelet TFPIα overexpression. Journal of thrombosis and haemostasis : JTH 19 (6) (2021)
Alan E Mast, Aniko Szabo, Mars Stone, Ritchard G Cable, Bryan R Spencer, Joseph E Kiss, null null
The benefits of iron supplementation following blood donation vary with baseline iron status. American journal of hematology 95 (7) (2020)
Bryan R Spencer, Matthew P Fox, Lauren A Wise, Ritchard G Cable, Alan E Mast
Iron status and self-reported fatigue in blood donors. Transfusion 61 (1) (2020)
Lisa Baumann Kreuziger, Gustaf Edgren, Ronald George Hauser, Daniel Zaccaro, Joseph Kiss, Matt Westlake, Donald Brambilla, Alan E Mast, null null
Red blood cell transfusion does not increase risk of venous or arterial thrombosis during hospitalization. American journal of hematology 96 (2) (2020)
Amy E Siebert, Alan E Mast
Platelet anticoagulant proteins: Modulators of thrombosis propensity within a procoagulant cell. Journal of thrombosis and haemostasis : JTH 18 (9) (2020)
Alan E Mast, John C Langer, Yuelong Guo, Walter Bialkowski, Bryan R Spencer, Tzong-Hae Lee, Joseph Kiss, Ritchard G Cable, Donald J Brambilla, Michael P Busch, Grier P Page, null null
Genetic and behavioral modification of hemoglobin and iron status among first-time and high-intensity blood donors. Transfusion 60 (4) (2020)
Paul E R Ellery, Ida Hilden, Peter Thyregod, Nicholas D Martinez, Susan A Maroney, Joan C Gill, Alan E Mast
Measurement of plasma and platelet tissue factor pathway inhibitor, factor V and Protein S in people with haemophilia. Haemophilia : the official journal of the World Federation of Hemophilia 25 (6) (2019)
Walter Bialkowski, Joseph E Kiss, David J Wright, Ritchard Cable, Rebecca Birch, Pam D'Andrea, Barbara J Bryant, Bryan R Spencer, Alan E Mast
Estimates of total body iron indicate 19 mg and 38 mg oral iron are equivalent for the mitigation of iron deficiency in individuals experiencing repeated phlebotomy. American journal of hematology 92 (9) (2017)